Concepedia

Prognostic Significance of Rising Serum CA-125 Levels Within the Normal Range in Patients With Epithelial Ovarian, Primary Peritoneal, and Tubal Cancers, Who, After Initial Treatment, Had a Complete Clinical Response

Tally Levy, Roi Weiser, Mona Boaz, Erez Ben Shem, Abraham Golan, Joseph Menczer

International Journal of Gynecological Cancer · 2012 · 10 citations · 11 references

DOI

Concepts

References

11

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Cancer Statistics, 2010

Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text

, , +16

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

Gordon Rustin, Maria EL van der Burg, Clare Griffin et al. · The Lancet · 2010 · 594 citations · Full text

, , +15

Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study

G.J.S. Rustin, Ann E. Nelstrop, Malgorzata Tuxen et al. · Annals of Oncology · 1996 · 286 citations · Full text

, , +12

Risk of Epithelial Ovarian Cancer Recurrence in Patients With Rising Serum CA-125 Levels Within the Normal Range

Antonio Santillan, Ruchi Garg, Marianna Zahurak et al. · Journal of Clinical Oncology · 2005 · 151 citations

, , +15